CIK 0001157601
- Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP, Corporate Development acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy President and CEO bought 20,000 shares at $3.75 ($75,000)
- 4 Open-market buy Director bought 13,333 shares at $3.75 ($49,999)
- 4 Open-market buy Director bought 150,000 shares at $3.75 ($562,500)
- 4 Open-market buy Director bought 5,000,000 shares at $3.75 ($18,750,000)
- 4 Grant or award Director acquired 4,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 16,000 shares (grant or award)
- 4 Grant or award Director acquired 2,000 shares (grant or award)
- 4 Grant or award Director acquired 8,000 shares (grant or award)
- 4 Open-market buy Director bought 150,000 shares at $4.71 ($706,515)
- 4 Open-market buy President and CEO bought 10,000 shares at $5.03 ($50,299)
Page 18 of 29 · 564 filings